| Literature DB >> 34249406 |
Yu-Shui Ma1,2,3, Ji-Bin Liu2, Xiao-Li Yang3, Rui Xin3, Yi Shi1,2, Dan-Dan Zhang3, Hui-Min Wang3, Pei-Yao Wang3, Qin-Lu Lin1, Wen Li1, Da Fu1,3.
Abstract
Chemotherapy is one of the main treatments for cancer, especially for advanced cancer patients. In the past decade, significant progress has been made with the research into the molecular mechanisms of cancer cells and the precision medicine. The treatment on cancer patients has gradually changed from cytotoxic chemotherapy to precise treatment strategy. Research into anticancer drugs has also changed from killing effects on all cells to targeting drugs for target genes. Besides, researchers have developed the understanding of the abnormal physiological function, related genomics, epigenetics, and proteomics of cancer cells with cancer genome sequencing, epigenetic research, and proteomic research. These technologies and related research have accelerated the development of related cancer drugs. In this review, we summarize the research progress of anticancer drugs, the current challenges, and future opportunities. AJCREntities:
Keywords: Drug therapy; cancer; comprehensive utilization; inhibitor
Year: 2021 PMID: 34249406 PMCID: PMC8263657
Source DB: PubMed Journal: Am J Cancer Res ISSN: 2156-6976 Impact factor: 6.166